Nucleus Genomics · Series A
AI-powered whole-genome DNA analysis for proactive health and family planning
Amount
$14M
Round
Series A
Valuation
—
Announced
Jan 2025
Investors
Lead investor
Seven Seven SixParticipating investors
AI-powered whole-genome DNA analysis for proactive health and family planning
Amount
$14M
Round
Series A
Valuation
—
Announced
Jan 2025
Lead investor
Seven Seven SixParticipating investors